International Journal of Pharmaceutical Sciences Research Volume 3 (2016), Article ID 3:IJPSR-111, 6 pages
Research Article
Suppressive Activity of Glucosamine Hydrochloride on Nitric Oxide Production from Synoviocytes In Vitro

Chiharu Ohta1, Asako Yamada2, Kuniko Yufune1 and Kazuhito Asano3*

1Graduate School of Nursing and Rehabilitation Sciences, Showa University Graduate School, Yokohama, Japan
2Division of Nursing, Showa University Rehabilitation Hospital, Showa University, Yokohama, Japan
3Division of Physiology, School of Nursing and Rehabilitation Sciences, Showa University, Yokohama, Japan
Prof. Kazuhito Asano, Division of Physiology, School of Nursing and Rehabilitation Sciences, Showa University, 1865 Touka-Ichiba, Midori-Ku, Yokohama 226-8555, Japan; E-mail:
16 November 2015; 17 January 2016; 19 January 2016
Ohta C, Yamada A, Yufune K, Asano K (2016) Suppressive Activity of Glucosamine Hydrochloride on Nitric Oxide Production from Synoviocytes In Vitro. Int J Pharma Sci Res 3: 111. doi:


  1. Chijimatsu R, Kunugiza Y, Taniyama Y, Nakamura N, Tomita T, et al. (2015) Expression and pathological effects of periostin in human osteoarthritis cartilage. BMC Musculoskeletal Disorders 16: 215-226. View
  2. Ishikawa S, Asano K, Kusayanagi H, Takashima M, Yoshida N, et al. (2015) Influence of periostin on synovial fibroblasts in knee osteoarthritis. Chronic Diseases-Int 2: id 1013. View
  3. Fitzsimmons RJ, Gordon SL, Kronberg J, Ganey T, Pilla AA (2008) A pulsing electric field (PF) increases human chondrocyte proliferation through a transduction pathway involving nitric oxide signaling. J Orthop Res 26: 854-859. View
  4. Kotlarz H, Gunnarsson CL, Fang H, Rizzo JA (2009) Insurer and out-ofpocket costs of osteoarthritis in the US: evidence from national survey data. Arthritis Rheum 60: 3546-3553. View
  5. Casagrande D, Stains JP, Murthi AM (2015) Identification of shoulder osteoarthritis biomarkers: comparison between shoulders with and without osteoarthritis. J Shoulder Elbow Surg 24: 382-390. View
  6. Abramson SB, Attur M, Yazici Y (2006) Prospects for disease modification in osteoarthritis. Nat Clin Pract Rheumatol 2: 304-312. View
  7. Daghestani HN, Kraus VB (2015) Inflammatory biomarkers in osteoarthritis. Osteoarthritis Cartilage 23: 1890-1896. View
  8. Abramson SB (2008) Osteoarthritis and nitric oxide. Osteoarthritis Cartilage 16 Suppl 2: S15-S20. View
  9. Abramson SB (2008) Nitric oxide in inflammation and pain associated with osteoarthritis. Arthritis Res Ther 10 Suppl 2: S2. View
  10. Veronesi F, Fini M, Giavaresi G, Ongaro A, Mattei M, et al. (2015) Experimentally induced cartilage degeneration treated by pulsed electromagnetic field stimulation; an in vitro study on bovine cartilage. BMC Musculoskeletal Disorders 16: 308. View
  11. Provenza JR, Shinjo SK, Silva JM, Peron CRGS, Rocha FAC (2015) Combined glucosamine and chondroitin sulfate, once or three times daily, provides clinically relevant analgesia in keen osteoarthritis. Clin Rheumatol 34: 1455-1462. View
  12. Gallagher B, Tjoumakaris FP, Harwood MI, Good RP, Ciccotti MG, et al. (2015) Chondroprotection and the prevention of osteoarthritis progression of the knee: a systematic review of treatment agents. Am J Sports Med 43: 734-744. View
  13. Henrotin Y, Marty M, Mobasheri A (2014) What is the current status of chondroitin sulfate and glucosamine for the treatment of knee osteoarthritis? Maturitas 78: 184-187. View
  14. Percope de Andrade MA, Campos TV, Abreu-E-Silva GM (2015) Supplementary methods in the nonsurgical treatment of osteoarthritis. Arthroscopy 31: 785-792. View
  15. Hochberg MC, Martel-Pelletier J, Monfort J, Moller I, Castillo JR, et al. (2015) Combined chondroitin sulfate and glucosamine for painful knee osteoarthritis: a multicenter, randomized, double-blind, non-inferiority trial versus celecoxib. Ann Rheum Dis 75: 37-44. View
  16. Blanchard C, Mingler MK, McBride M, Putnam PE, Collins MH, et al. (2008) Periostin facilitates eosinophil tissue infiltration in allergic lung and esophageal responses. Mucosal Immunol 1: 289-296. View
  17. Uchida M, Shiraishi H, Ohta S, Arima K, Taniguchi K, et al. (2012) Periostin, a matricellular protein, plays a role in the induction of chemokines in pulmonary fibrosis. Am J Respir Cell Mol Biol 46: 677-686. View
  18. Takeshita S, Kikuno R, Tezuka K, Amann E (1993) Osteoblast-specific factor 2: cloning of a putative bone adhesion protein with homology with the insect protein fasciclin I. Biochem J 294 : 271-278. View
  19. Lin SJ, Lu HK, Lee HW, Chen YC, Li CL, et al. (2012) Nitric oxide inhibits androgen receptor-mediated collagen production in human gingival fibroblasts. J Periodontal Res 47: 701-710. View
  20. Reginster JY, Deroisy R, Rovati LC, Lee RL, Lejeune E, et al. (2001) Long-term effects of glucosamine sulphate on osteoarthritis progression: a randomised, placebo-controlled clinical trial. Lancet 357: 251-256. View
  21. Sawitzke AD, Shi H, Finco MF, Dunlop DD, Harris CL, et al. (2010) Clinical efficacy and safety of glucosamine, chondroitin sulphate, their combination, celecoxib or placebo taken to treat osteoarthritis of the knee: 2-year results from GAIT. Ann Rheum Dis 69: 1459-1464. View
  22. Persiani S, Roda E, Rovati LC, Locatelli M, Giacovelli G, et al. (2005) Glucosamine oral bioavailability and plasma pharmacokinetics after increasing doses of crystalline glucosamine sulfate in man. Osteoarthritis Cartilage 13: 1041-1049. View
  23. Naito K, Watari T, Furuhata A, Yomogida S, Sakamoto K, et al. (2010) Evaluation of the effect of glucosamine on an experimental rat osteoarthritis model. Life Sci 86: 538-543. View
  24. Persiani S, Rotini R, Trisolino G, Rovati LC, Locatelli M, et al. (2007) Synovial and plasma glucosamine concentrations in osteoarthritic patients following oral crystalline glucosamine sulphate at therapeutic dose. Osteoarthritis Cartilage 15: 764-772. View
  25. Wang ZQ, Porreca F, Cuzzocrea S, Galen K, Lightfoot R, et al. (2004) A newly identified role for superoxide in inflammatory pain. J Pharmacol Exp Ther 309: 869-878. View
  26. Masuoka M, Shiraishi H, Ohta S, Suzuki S, Arima K, et al. (2012) Periostin promotes chronic allergic inflammation in response to Th2 cytokines. J Clin Invest 122: 2590-2600. View
  27. Izuhara K, Arima K, Ohta S, Suzuki S, Inamitsu M, et al. (2014) Periostin in allergic inflammation. Allergol Int 63: 143-151. View
  28. Yi HA, Yi SD, Jang BC, Song DK, Shin DH, et al. (2005) Inhibitory effects of glucosamine on lipopolysaccharide-induced activation in microglial cells. Clin Exp Pharmacol Physiol 32: 1097-1103. View
  29. Nagy T, Champattanachai V, Marchase RB, Chatham JC (2006) Glucosamine inhibits angiotensin II-induced cytoplasmic Ca2+ elevation in neonatal cardiomyocytes via protein-associated O-linked N-acetylglucosamine. Am J Physiol Cell Physiol 290: C57-C65. View
  30. Hong H, Park YK, Choi MS, Ryu NH, Song DK, et al. (2009) Differential down-regulation of COX-2 and MMP-13 in human skin fibroblasts by glucosamine-hydrochloride. J Dermatol Sci 56: 43-50. View
  31. Chou WY, Chuang KH, Sun D, Lee YH, Kao PH, et al. (2015) Inhibition of PKC-induced COX-2 and IL-8 expression in human breast cancer cells by glucosamine. J Cell Physiol 230: 2240-2251. View